Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amgen Inc. stock logo
AMGN
Amgen
$465.23
+1.0%
$423.08
$312.39
▼
$483.99
$258.68B0.432.76 million shs2.31 million shs
Microsoft Corporation stock logo
MSFT
Microsoft
$545.18
+2.7%
$517.28
$349.20
▼
$559.15
$4.13T1.0524.07 million shs25.29 million shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amgen Inc. stock logo
AMGN
Amgen
+1.04%-0.05%+12.14%+12.29%+45.29%
Microsoft Corporation stock logo
MSFT
Microsoft
+2.75%+7.51%+1.89%+8.21%+9.73%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amgen Inc. stock logo
AMGN
Amgen
$465.23
+1.0%
$423.08
$312.39
▼
$483.99
$258.68B0.432.76 million shs2.31 million shs
Microsoft Corporation stock logo
MSFT
Microsoft
$545.18
+2.7%
$517.28
$349.20
▼
$559.15
$4.13T1.0524.07 million shs25.29 million shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amgen Inc. stock logo
AMGN
Amgen
+1.04%-0.05%+12.14%+12.29%+45.29%
Microsoft Corporation stock logo
MSFT
Microsoft
+2.75%+7.51%+1.89%+8.21%+9.73%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Amgen Inc. stock logo
AMGN
Amgen
2.30
Hold$422.76-9.13% Downside
Microsoft Corporation stock logo
MSFT
Microsoft
2.94
Moderate Buy$609.5411.81% Upside

Current Analyst Ratings Breakdown

Latest AMGN and MSFT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/6/2026
Microsoft Corporation stock logo
MSFT
Microsoft
Initiated CoverageBuy
11/6/2026
Amgen Inc. stock logo
AMGN
Amgen
DowngradeBuy ➝ Hold$450.00 ➝ $470.00
11/5/2026
Amgen Inc. stock logo
AMGN
Amgen
Boost Price TargetMarket Perform$395.00 ➝ $464.00
11/5/2026
Amgen Inc. stock logo
AMGN
Amgen
Boost Price TargetNeutral$378.00 ➝ $435.00
11/4/2026
Amgen Inc. stock logo
AMGN
Amgen
Boost Price TargetBuy$452.00 ➝ $531.00
11/4/2026
Amgen Inc. stock logo
AMGN
Amgen
Boost Price TargetMarket Perform$345.00 ➝ $400.00
11/4/2026
Amgen Inc. stock logo
AMGN
Amgen
Boost Price TargetOutperform$430.00 ➝ $470.00
11/4/2026
Amgen Inc. stock logo
AMGN
Amgen
Boost Price TargetHold$384.00 ➝ $440.00
11/4/2026
Amgen Inc. stock logo
AMGN
Amgen
Boost Price TargetEqual Weight$430.00 ➝ $460.00
11/4/2026
Amgen Inc. stock logo
AMGN
Amgen
Reiterated RatingOutperform
11/4/2026
Amgen Inc. stock logo
AMGN
Amgen
Boost Price TargetBuy$470.00 ➝ $530.00
(Data available from 11/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Amgen Inc. stock logo
AMGN
Amgen
$36.75B6.84$32.88 per share14.15$26.55 per share17.52
Microsoft Corporation stock logo
MSFT
Microsoft
$331.84B12.20$22.10 per share24.67$63.36 per share8.60
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Amgen Inc. stock logo
AMGN
Amgen
$7.71B$17.2426.9918.613.4724.14%114.99%13.47%N/A
Microsoft Corporation stock logo
MSFT
Microsoft
$133.75B$19.1628.4522.921.6441.17%31.28%18.55%1/27/2027 (Estimated)

Latest AMGN and MSFT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/3/2026Q3 2026
Amgen Inc. stock logo
AMGN
Amgen
$5.79$6.45+$0.66$7.08$10.07 billion$10.37 billion
10/28/2026Q1 2027
Microsoft Corporation stock logo
MSFT
Microsoft
$4.72$4.89+$0.17$4.92$90.62 billion$92.28 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Amgen Inc. stock logo
AMGN
Amgen
$10.082.17%+8.27%58.47%14 Years
Microsoft Corporation stock logo
MSFT
Microsoft
$3.640.67%+10.21%19.00%23 Years

Latest AMGN and MSFT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/27/2026
Amgen Inc. stock logo
AMGN
Amgen
quarterly$2.522.25%11/20/202611/20/202612/11/2026
9/14/2026
Microsoft Corporation stock logo
MSFT
Microsoft
quarterly$0.980.79%11/19/202611/19/202612/10/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Amgen Inc. stock logo
AMGN
Amgen
3.60
1.48
1.13
Microsoft Corporation stock logo
MSFT
Microsoft
0.07
1.22
1.21

Institutional Ownership

CompanyInstitutional Ownership
Amgen Inc. stock logo
AMGN
Amgen
76.50%
Microsoft Corporation stock logo
MSFT
Microsoft
71.13%

Insider Ownership

CompanyInsider Ownership
Amgen Inc. stock logo
AMGN
Amgen
0.85%
Microsoft Corporation stock logo
MSFT
Microsoft
0.03%
CompanyEmployeesShares OutstandingFree FloatOptionable
Amgen Inc. stock logo
AMGN
Amgen
31,500540.63 million536.31 millionOptionable
Microsoft Corporation stock logo
MSFT
Microsoft
223,0007.43 billion7.42 billionOptionable

Recent News About These Companies

Do Wall Street Analysts Like Microsoft Stock?
Microsoft (MSFT) Signs Global AI Safety Declaration
Bill Gates Microsoft Copilot AI Predicts a SOL Crypto Explosion
Microsoft (NASDAQ:MSFT) Shares Up 2.7% - Here's Why
Microsoft: The AI Numbers Are Telling Two Stories

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Amgen stock logo

Amgen NASDAQ:AMGN

$465.23 +4.81 (+1.04%)
Closing price 11/9/2026 04:00 PM Eastern
Extended Trading
$468.67 +3.44 (+0.74%)
As of 05:32 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Microsoft stock logo

Microsoft NASDAQ:MSFT

$545.18 +14.57 (+2.75%)
Closing price 11/9/2026 04:00 PM Eastern
Extended Trading
$541.85 -3.33 (-0.61%)
As of 05:38 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Microsoft Corporation develops and supports software, services, devices and solutions worldwide. The Productivity and Business Processes segment offers office, exchange, SharePoint, Microsoft Teams, office 365 Security and Compliance, Microsoft viva, and Microsoft 365 copilot; and office consumer services, such as Microsoft 365 consumer subscriptions, Office licensed on-premises, and other office services. This segment also provides LinkedIn; and dynamics business solutions, including Dynamics 365, a set of intelligent, cloud-based applications across ERP, CRM, power apps, and power automate; and on-premises ERP and CRM applications. The Intelligent Cloud segment offers server products and cloud services, such as azure and other cloud services; SQL and windows server, visual studio, system center, and related client access licenses, as well as nuance and GitHub; and enterprise services including enterprise support services, industry solutions, and nuance professional services. The More Personal Computing segment offers Windows, including windows OEM licensing and other non-volume licensing of the Windows operating system; Windows commercial comprising volume licensing of the Windows operating system, windows cloud services, and other Windows commercial offerings; patent licensing; and windows Internet of Things; and devices, such as surface, HoloLens, and PC accessories. Additionally, this segment provides gaming, which includes Xbox hardware and content, and first- and third-party content; Xbox game pass and other subscriptions, cloud gaming, advertising, third-party disc royalties, and other cloud services; and search and news advertising, which includes Bing, Microsoft News and Edge, and third-party affiliates. The company sells its products through OEMs, distributors, and resellers; and directly through digital marketplaces, online, and retail stores. The company was founded in 1975 and is headquartered in Redmond, Washington.